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Natural killer (NK) t cell activity (1, 2) is mediated by a small but heterogeneous 
population of peripheral  blood mononuclear cells (PBMC), which are morpho- 
logically classified as large granular lymphocytes (LGL). Although not completely 
elucidated, the mechanisms of target cell lysis by different types of NK cells are 
believed to be similar (2,  3).  The  initial  binding of the NK effector cell to the 
target cell occurs through the recognition of a determinant on the target cell by 
a specific receptor on the effector cell (2, 3). Perturbation of a separate NK cell 
membrane structure (4) leads to activation of the NKcell by a calcium-dependent 
process, resulting  in an  increase in phospholipase  A2 activity. Target cell lysis, 
which is also calcium-dependent,  is postulated to result from the deposition on 
the  plasma  membrane  of lytic  molecules (5,  6)  exocytosed with  the  secretory 
granules of the effector cell. After this event, the calcium-independent lethal hit 
stage of cytotoxicity occurs (7) with the formation  of transmembrane  channels 
on the target cell (8, 9). 
Dourmashkin  et al. (8) observed by electron microscopy that in cell-mediated 
cytolysis, human peripheral blood leukocytes formed ring-like structures with an 
internal diameter of 15 nm on the target cell. Henkart and Henkart (9) observed 
that formation of the ring structures was due to material (designated as cytolysin) 
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that was released with the cytoplasmic granules of the effector cell. They and 
their associates also showed (10, 11) that isolated granules from rat LGL leukemia 
cells  mediated  cellular  cytotoxicity with  the  concomitant formation of ring- 
structured lesions.  Podack and  Dennert (12),  using cloned mouse NK cells  as 
effectors and both YAC-1  cells and rabbit erythrocytes as targets, demonstrated 
the formation of two types of membrane lesions with inner diameters of either 
16 +  2 nm (~160 A) or ~5 nm (~50 A) on the targets. NK cells (12) are believed 
to  interact  with  susceptible  targets  to  assemble  monomeric  precursors  into 
polymerized  complexes  that  probably  contain  hydrophobic  and  hydrophilic 
domains, thereby allowing the formation of transmembrane channels and target 
cell lysis (12,  13). 
Proteoglycans are  glycoconjugates that  consist  of a  polypeptide core  with 
covalently linked oligosaccharides and glycosaminoglycan side chains (14).  Al- 
though  most  of the  proteoglycans  in  mammals  are  located  in  extracellular 
matrices  and  are  protease-susceptible,  IgE-Fc-bearing  cells  contain  protease- 
resistant proteoglycans in their secretory granules (15,  16). Heparin proteogly- 
cans are present in the secretory granules of rat (15) and mouse (17) serosal mast 
cells,  and  human  lung  (18)  and  skin  (19)  mast  cells.  Chondroitin  sulfate  E 
proteoglycan and chondroitin sulfate di-B proteoglycan are present in the gran- 
ules of interleukin 3-dependent mouse bone marrow-derived mast cells (17, 20) 
and  in  rat  basophilic  leukemic  cells  (16),  respectively.  The  negative  charge 
characteristics of these intracellular proteoglycans make them particularly well 
suited as storage and carrier molecules for basically charged proteases and other 
proteins that are present in secretory granules and are exocytosed in response to 
a specific stimulus. We investigated the human NK clone JTB18, which has the 
plasma membrane phenotype of human peripheral blood NK cells (21),  and a 
defined target cell specificity (22),  to determine whether it possesses  proteogly- 
cans in its granules. We determined that this cloned human NK cell contains a 
cell-associated  chondroitin  sulfate  A  proteoglycan  which  is  localized  to  the 
granules of the cell and is specifically exocytosed when the NK cell lyses suscep- 
tible tumor cells. 
Materials and Methods 
Materials.  RPMI 1640, fetal calf  serum, 2-mercaptoethanol, L-glutamine, nonessential 
amino acids, penicillin, and streptomycin were obtained from Gibco Laboratories, (Grand 
Island,  NY); PD-10 gel  filtration  columns, Sepharose  CL-4 B and CL-6 B were from 
Pbarmacia  Fine  Chemicals (Piscataway, NJ); [35S]sulfate (sp  act  ~4,000  Ci/mol)  was 
obtained  from  New  England  Nuclear  (Boston, MA); Hydrofluor was  from  National 
Diagnostics (Somerville, N  J); Streptomyces griseus pronase (77 U/rag) and Zwittergent  3- 
12 were purchased from Calbiochem-Behring Corp. (San Diego, CA); ultrapure guanidine 
hydrochloride (GnHCI) was from Schwarz/Mann (Spring Valley, NY); phytohemaggluti- 
nin was supplied by Burroughs Wellcome (Research Park, NC); phorbol myristate acetate 
and porcine  heparin  were  obtained from  Sigma Chemical  Co.  (St. Louis,  MO); and 
Staphylococcus aureus V8 protease (570 U/mg), shark chondroitin sulfate C, whale chon- 
droitin sulfate A, and chondroitinase  ABC and AC were purchased  from Miles Labora- 
tories (Elkhart, IN). 
Culture of a Human  Cloned NK Cell Line.  The method for the generation of human 
cloned  NK cells has been  described  (22, 23). Cloned JTB18 cells derived  from PBMC 
were cloned at 1 cell/well on a feeder layer of allogeneic irradiated (5,000 rad) PBMC 
and allogeneic irradiated (5,000  tad) Epstein-Barr  virus (EBV)-transformed B cells in MAcDERMOTT  ET  AL.  1773 
medium containing 2 ~g/ml of phytohemagglutinin. The JTB18 NK cloned cell line was 
selected for its ability to lyse K562 target cells, and the clone was expanded by culture in 
RPMI  1640  supplemented  with  1%  penicillin,  1%  streptomycin,  1%  sodium pyruvate, 
20% human AB serum (enriched medium)and  10-15% (vol/vol) lymphocyte-conditioned 
medium  (LCM).  The culture  medium  was replaced every  3  d.  LCM was produced by 
stimulating whole PBMC at a  concentration of 2.5  ×  106 cells/ml for 2 h  with 5 t~g/ml 
phytohemagglutinin,  5 ng/mi phorbol myristate acetate and 5,000 rad-irradiated  EBV- 
transformed B cells (0.5 ×  106 cells/ml) (21-24). The activated PBMC were then washed 
four times to remove the mitogens, and were resuspended in RPMI 1640 supplemented 
with 2.5% human AB serum. After 40 h of incubation at 37°C, the cells were pelleted at 
500  g,  and  the  LCM  was  sterilized  by passage  through  0.45  #m  filters  and  stored  at 
-70°C  until it was used for cloning or subcloning the JTB18 cells (21-24).  All NK cells 
used in these studies were subcloned at least four times at 100 cells/well on a feeder layer 
of allogeneic irradiated  PBMC plus irradiated  EBV-transformed B cells. The phenotype 
of the cloned JTB18 NK cells is characteristic of peripheral  blood NK cells: T3-, T11 ÷, 
NKH1 ÷, and  NKH2-  (22).  After  subcloning procedures,  both  the  phenotype  and  the 
cytotoxic function of this cell line remained stable. 
Human NKH1A  + LGL were obtained by first staining PBMC with anti-NKH1A antibody 
and  mouse  Fab  IgG  labeled  with  fluorescein  isothiocyanate,  and  then  separating  the 
NKH 1A  ÷ cells from the NKH 1  A- cells by use of the cell sorter (Epics V; Coulter Electronics, 
Hialeh, FL) (21). 
Microscopic and x-ray  Energy-dispersive  Analysis  of Cloned  NK Cells.  For transmission 
electron  microscopy,  preparations  of LGL  (4.0-5.5  ×  105  cells)  were  fixed  with  2% 
glutaraldehyde  in 0.1  M  cacodylate, pH  7.2,  and were stored  for  1 wk or  17  h  in  7% 
sucrose in 0.1  M  cacodylate, pH  7.2.  The cells were pooled, pelleted  in a  Microfuge B 
(Beckman Instruments,  Palo Alto, CA), postfixed in  1%  OsO4 in acetate veronal buffer, 
stained in block with uranyl acetate, dehydrated in graded ethanols and propylene oxide, 
and embedded in Epon 812. JTB18 (2 ×  106 cells/ml of enriched medium) were fixed by 
the addition of an equal volume of mixed aldehydes in cacodylate for 45 min at 4 °C (25), 
pelleted and processed as above for transmission microscopy. For x-ray energy-dispersive 
spectroscopy,  the JTB18  cells  were  fixeql  in  aldehydes  (25),  pelleted,  dehydrated,  and 
embedded.  Thin sections were cut with  silver-gold interference  colors for transmission 
microscopy and with gold interference colors for x-ray analysis. Sections were picked up 
on naked copper grids, and were stained with uranyl acetate and lead citrate for trans- 
mission microscopy, and with uranyl acetate for x-ray analysis. Grids were examined in a 
JEOL 100C/ASID electron microscope equipped with a Kevex 7000 x-ray analysis system. 
x-ray specimens  were  observed  in  the  scanning.transmission  mode  at  an  accelerating 
voltage of 80 kV using a probe diameter of<100 A (26). Elemental spectra were recorded 
from granules, cytoplasm, nuclei, and the epoxy resin over 100-s counting intervals. The 
sulfur window, 2.24-2.42 keV, consisted of 10 channels (20 eV/channel) centered around 
the characteristic sulfur emission (K, =  2.32 keV). Background values were determined 
by a program that averaged the two channels immediately adjacent to the high and low 
limits of the sulfur window and extrapolated linearly between the two values. Sulfur peaks 
(Ps) were considered to be significantly above background (Bg) when Ps >  Bg +  3 
(see  27 for discussion of this analysis). Three separate  preparations of JTB18 cells were 
examined by transmission microscopy and two preparations by x-ray analysis. 
Radiolabeling  of NK-cloned  Cells  and  Characterization  of Cell-associated Proteoglycans. 
JTB18 cells were incubated at  37°C for 24 h  at a  concentration of 2  ×  10  6  cells/ml of 
enriched  medium  containing  10%  LCM  and  100  #Ci/ml  of [sSS]sulfate.  Radiolabeled 
cloned NK cells were sedimented at 400 g for 5 min, the supernatants were removed and 
saved,  and  the  cells  were  washed  once  with  medium.  The  cell-associated  35S-labeled 
proteoglycans were extracted by the addition of 50 ~1 of 1% (vol/voi) Zwittergent 3-12, 
followed  30  s  later  by 450  ~1  of 4  M  GnHCI (17).  Heparin  or chondroitin  sulfate  A 
glycosaminoglycan (1  mg) was added to each extract as a carrier to minimize nonspecific 
absorption and  loss of the radiolabeled  proteoglycans during their  isolation.  The  24 h 
culture  medium  supernatants,  which  contained  the  35S-labeled  proteoglycans released 1774  PROTEOGLYCANS  IN  CELL-MEDIATED  CYTOTOXICITY 
during the radiolabeling, were made 4 M in GnHCI by the addition of an equal volume 
of 8 M GnHCI. Solid CsCI was added to each sample to give a final density of 1.4 g/ml, 
and the cell extracts and supernatants were centrifuged separately in a Beckman L2-65B 
ultracentrifuge at 95,000 g for 40-48  h  (17).  The bottom half of each gradient, which 
contained the 35S-labeled  proteoglycans, was dialyzed (3,000 Mr cut-off dialysis tubing) 
sequentially against  1 M sodium acetate for one exchange, and then against ammonium 
bicarbonate for five exchanges to remove the GnHCI and free [35S]sulfate. 
To  determine  the  hydrodynamic  size  of the  35S-labeled  NK cell  proteoglycan,  the 
samples were dialyzed, lyophilized, and suspended in 500 #1 of H~O, and portions were 
applied to Sepharose CL-4 B columns (0.6 ×  120 cm) that were equilibrated in and eluted 
with 4  M GnHCI, 0. I  M Tris-HC1, 0.1  M  Na~SO4, pH 7.0 (TSG buffer), containing 25 
ug/ml of heparin glycosaminoglycan carrier (17).  A sample of each 0.5-ml column eluate 
fraction was added to 0.5  ml of 70% (vol/vol) ethanol and  12.5 ml of Hydrofluor, and 
the radioactivity was quantitated on a Searle 6880 Beta Counter.  For protease suscepti- 
bility studies,  ~ 1 #g of the density gradient-purified 35S-labeled  proteoglycan was sus- 
pended  in  100  #1  of Hanks' balanced salt  solution,  and  was  incubated  with  1 mg of 
pronase, or with 3 or 100 U ofS. aureus  V8 protease for 1 b at 37°C. The digests were 
made 4 M in GnHCI and the 35S-labeled proteoglycans were analyzed for their hydrody- 
namic  size  by Sepharose  CL-4  B  gel  filtration.  To  determine  their  approximate size, 
glycosaminoglycans were liberated from purified 35S-labeled JTB18 proteoglycans by/3- 
elimination in 30 #1 of 0.5  M NaOH for 16 h at 4°C followed by neutralization with 30 
#1 of 0.5 M acetic acid. Each sample was then chromatographed on a 0.7 ×  100-cm column 
of Sepharose CL-6 B that had been equilibrated with TSG containing 50 #g/ml heparin. 
0.5-ml fractions were collected and  analyzed for radioactivity. The  relative molecular 
weights (Mr) of the glycosaminoglycan side chains were estimated by comparing the Kay 
values to published Kav values for glycosaminoglycans of known Mr (28). 
The 35S-labeled disaccharides were identified by enzymatic digestion of the 35S-labeled 
proteoglycan, followed by high performance liquid chromatographic (HPLC) analysis of 
the digests. After the addition of chondroitin sulfate C (100 ug) and chondroitin sulfate 
A (100 #g) carriers, 3~S-labeled NK cell proteoglycans were incubated at 37 °C for 60 min 
with  0.4  U  of chondroitinase  ABC or with  0.4  U  of chondroitinase  AC,  as previously 
described (17,  29).  The extent of digestion was assessed by Sephadex G-25/PD-10 gel 
filtration chromatography of a  250-#1 portion of each digest on separate  1.5  ×  5.5  cm 
columns,  which  were equilibrated  and  eluted  with  TSG;  the  amounts of radioactivity 
eluting in the void volume and in the included volume of each column were determined. 
For HPLC analysis of the chondroitinase digests, liberated 35S-labeled disaccharides were 
separated  from  undegraded  proteoglycans,  glycosaminoglycans, degradative  enzymes, 
and contaminating macromolecules by an 80% ethanol extraction. Each digest was diluted 
with  four  volumes of absolute  ethanol,  cooled  to  0°C  for  2  h,  and  centrifuged  in  a 
Beckman Microfuge at 8,000 g for 5 min. The supernatants were decanted, dried over 
nitrogen, and resuspended in the HPLC solvent composed of 70% acetonitrile/methanol 
(3:1,  vol/vol) and  30%  0.5  M ammonium acetate/acetic acid,  pH 5.3.  HPLC was per- 
formed on an Altex Model 322 system (Altex Scientific, Berkeley, CA) using a 4.6 ×  250- 
mm Whatman Partisil-10 PAC amino-cyano-substituted normal-phase silica column with 
a 4.6 ×  24-ram precolumn containing the same packing (Whatman Inc., Clifton, NJ), as 
previously described (30).  The elution of the ~sS-labeled  disaccharides was characterized 
relative to authentic  disaccharide  standards:  2-acetamido-2-deoxy-3-O-(/3-D-gluco-4-ene- 
pyranosyluronic acid)-4-O-sulfo-D-galactose  (ADi-4S), 2-acetamido-2-deoxy-3-O-03-D-gluco- 
4-enepyranosyluronic acid)-6-O-sulfo-D-galactose (ADi-6S), and 2-acetamido-2-deoxy-3-O- 
(/3-D-gluco-4-enepyranosyluronic acid)-4,6-di-O-sulfo-D-galactose (ADi-diSE) (30). 
Cytotoxicity  Assays.  Cytotoxicity assays with  human  tumor lines used as targets were 
performed according to a  standard  chromium-release method (21-24).  The K562 cell 
line was established from a patient with chronic myeiogenous leukemia and the KG1 cell 
line from a patient with acute myeloblastic leukemia. REX, Molt4, and CEM are human 
T  cell  leukemic cell lines, and  Laz156 is an  EBV-transformed B cell line.  Chromium- 
release assays were performed in triplicate using V-bottom microtiter plates containing MAcDERMOTT  ET  AL.  1775 
RPMI  1640,  5%  normal human  AB serum, and  1% penicillin-streptomycin at various 
effector/target cell ratios with 5,000 target cells/well. 
Exocytosis of3~S-labeled Proteoglycan  from NK Effector Cells During Interaction with Target 
Cells.  After being labeled with [sSS]sulfate,  the cloned NK cells were centrifuged and 
washed once to remove most of the unincorporated [35S]sulfate. 2.5 x  104 s~S-labeled NK 
cells were incubated in quadruplicate with K562 or KG1  cells  in V-bottom microtiter 
plates for 30 min to 4 h. The number of 35S-labeled NK effector cells (2.5  ×  104) was 
held constant, and the number of K562 or KG1 target cells was varied to obtain effec- 
tor/target cell ratios ranging from  10:1  to 0.125:1.  After incubation in the microtiter 
plates, 150-#1 supernatants from two wells containing the same target cells were pooled, 
resulting in  two  300-#1  duplicate  samples  for each  target  cell.  Each  300-#1 duplicate 
supernatant sample was mixed with 25 #1 of chondroitin sulfate A carrier and 250 #1 of 8 
M  GnHCI and applied to separate Sephadex G-25/PD-10 columns, which were equili- 
brated and eluted with TSG to determine the total macromolecular radioactivity in the 
supernatants and extracts. Eight 0.5-ml fractions were collected. After the addition of 0.5 
ml ethanol and  12.5  ml  Hydrofluor to each fraction, sSS-radioactivity  was quantitated 
with a B-scintillation  counter. The net percent release of s~S-labeled proteoglycan from 
the  NK  effector cell was  calculated  as  100  ×  (experimental  -  minimal)/(maximal  - 
minimal) where experimental is the amount of sSS-radioactivity  (cpm) released from the 
effector cell in the presence of target cells;  minimal is the amount of the radioactivity 
(cpm) nonspecifically released when target cells were not present; and maximal is the total 
amount ofS~S-labeled proteoglycan (cpm) extractable from the ssS-labeled  effector cells. 
The maximal content was determined by lysing the ~sS-iabeled NK cells with 1% Nonidet 
P-40  detergent,  and  quantifying  the  total  amount  of 35S-labeled  proteoglycan.  The 
minimal release in eight experiments was 8.5 + 4.5% (mean __. SD) of the maximal release. 
Results 
Ultrastructural Analysis of LGL and the Cloned JTB18 NK Cell.  LGL obtained 
by  fluorescence-activated cell  sorting  of NKH1A-stained  human  PBMC  were 
homogeneous in appearance, with individual cells measuring 6-10 #m in diam- 
eter (Fig.  1).  The cells were mononuclear with a  cytoplasm rich in organelles. 
Mitochondria, Golgi apparatus, and 0.1-0.2 #m electron-dense granules tended 
to cluster in  the  cell where the  nucleus  was  indented.  The granules  varied  in 
number from cell to cell,  were homogeneous in electron density, and  did not 
contain parallel tubular arrays (Fig.  1, inset). JTB18 cells measured 6-10 ttm in 
diameter, and appeared to be similar to the LGL in the distribution and diversity 
of their subcellular organeiles (Fig.  2). Their granules were small and homoge- 
neous in electron density (Fig. 2, inset). The nucleus was occasionally invaginated 
and consequently appeared to surround portions of the cytoplasm. 
Incorporation of [35S]Sulfate  into Cloned JTB18 Cells and Characterization  of Their 
Proteoglycan.  As assessed by PD-10  chromatography under dissociative condi- 
tions,  the JTB18  cells  incorporated  [~SS]sulfate  into  total,  cell-associated,  and 
released macromolecules at linear rates of 622, 476, and  146 cpm/h/106 cells, 
respectively (Fig.  3).  After  24  h  of culture,  only 23%  of the  total  ~sS-labeled 
macromolecules were recovered in the culture medium in this experiment, while 
in  a  second  experiment,  26%  of  the  total  35S-labeled  macromolecules  were 
recovered  in  the  culture  medium  after  12  h  of culture.  Upon  CsC1  density- 
gradient  centrifugation  under  dissociative  conditions,  80%  of the  ~S-iabeled 
macromolecules in both the cell extract and in the culture medium sedimented 
to the bottom half of the gradient, indicating the presence of proteoglycan-like 
molecules with high buoyant densities. Gel filtration on Sepharose CL-4 B under 1776  PROTEOGLYCANS  IN  CELL-MEDIATED  CYTOTOXICITY 
FIGURE  l.  Transmission  electron  micrograph  of  human  LGL  isolated  by  fluorescence- 
activated  cell  sorting.  The  ceils  contain  a  single  nucleus  (n).  Most  organelles,  including 
mitochondria  (m),  Golgi  apparatus  (g),  and  granules  (gr),  are  clustered  near  the  nuclear 
indentation. The  inset is a  high magnification of the granules showing their homogeneous 
electron-dense structure, x  10,500. Inset, ×  64,000. MAcDERMOTT  ET  AL.  1777 
FIGURE 2.  Transmission  electron  micrograph  of JTB18  ceils.  The  nuclei  (n)  are  deeply 
invaginated and appear to surround portions of the cytoplasm in areas (arrows). Mitochondria 
(ra), Golgi apparatus (g), and granules (gr) are clustered as in the LGL. The granules are shown 
at higher power in the inset, and appear to be similar to those shown in Fig.  1 inset, x  9,600. 
Inset, x  78,000. 1778  PROTEOGLYCANS IN  CELL-MEDIATED CYTOTOXIC1TY 
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FIGURE 3.  Kinetics  of [35S]sulfate incorporation  into macromolecules  by cultured JTBI8 
cells.  106 cells were cultured at a density  of 2 x  106 cells/ml  of standard culture medium 
containing  100  #Ci  of [35S]sulfate and  the  total  (f-l), cell-associated  (A) and  released  (O) 
radiolabeled  macromolecules  were quantified  at defined intervals. 
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FIGURE 4.  (a)  Sepharose  CL-4 B chromatography of ssS-labeled, density gradient-purified 
cell-associated proteoglycans synthesized by JTB18 cells and filtered  before (0) and after ((3) 
incubation  with pronase. (b)  Sepharose CL-6 B chromatography of sSS-labeled NK cell glycos- 
aminoglycans. Vo and V~ mark the excluded and total volumes of the columns, respectively. 
dissociative  conditions  revealed  that  the  ceil-associated  and  the  secreted  SSS- 
labeled  proteoglycans from the  cloned  NK cells exhibited  a  predominant  poly- 
dispersed  peak  with  K~v values of 0.47  +  0.02  (mean  _+ SD, n  =  3) and  0.42  + 
0.05 (mean _+ SD, n  =  3), respectively, corresponding to ~200,000 Mr (Fig. 4 A). 
The  hydrodynamic size of the  ~SS-labeled  NK cell proteoglycan was not altered 
by incubation  of the  sSS-labeled  NK  proteoglycan  with  either  pronase  (n  =  2) 
(Fig.  4A)  or  S.  aureus  V8  protease  (n  =  3)  (data  not  shown)  before  the  gel 
filtration.  The  glycosaminoglycans liberated  from  the  35S-labeled  proteoglycan 
filtered on Sepharose CL-6 B with a  Kay of 0.31  +  0.02 (mean +  SD, n  =  3) (Fig. 
4B), indicating ~50,000  Mr. 
When the  3~S-labeled cell-associated  macromolecules were treated  with chon- 
droitinase  ABC or chondroitinase  AC, 89%  (mean; n  =  3) and 92% (mean; n  -- MAcDERMOTT  ET  AI  1779 
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FIGURE 5.  HPLC  analysis of a  chondroitinase AC digest of density gradient-purified ssS- 
labeled proteoglycan from JTB18 cloned cells, The retention times of standard disaccharides 
are indicated. 
2) of the  starting  material,  respectively, were digested to 35S-labeled disaccha- 
rides, as assessed by a shift of radioactivity from the void volume to the included 
volume on Sephadex G-25/PD-10. Duplicate samples, digested with either chon- 
droitinase ABC (n =  2) or chondroitinase  AC (n =  1) (Fig.  5) and analyzed for 
35S-labeled disaccharides by HPLC, revealed in each instance a single radioactive 
peak eluting at 6.9 min corresponding in its retention time with the unsaturated 
standard  disaccharide  ADi-4S.  That  ADi-4S  was generated  by treatment  with 
either  chondroitinase  ABC  or  chondroitinase  AC  indicated  that  most  of the 
disaccharides  in  the  chondroitin  sulfate  chain  contained  the  glucuronic  acid 
isomer  rather  than  the  iduronic  acid  isomer  of the  uronic  acid.  Thus,  the 
glycosaminoglycans of the protease-resistant proteoglycan of the human NK cell 
were predominantly chondroitin sulfate A (chondroitin-4-sulfate). 
Granule Localization of the Cell-associated Proteoglycan.  x-ray energy-dispersive 
spectroscopy was  performed  on  the  granules,  nucleus,  and  cytoplasm  of the 
JTB18 cells, and on the Epon embedding matrix. The sections were stained with 
uranyl  acetate  before  analysis  in  order  to  visualize  the  granules.  The  Epon 
contained only chlorine; the cytoplasm chlorine and uranium;  the nucleus phos- 
phorus, uranium,  and chlorine; and the granules sulfur, uranium,  and chlorine 
(Fig.  6).  The  granule  sulfur  peaks  were significantly  (>99%)  above the  back- 
ground in 30 of the 36 granule spectra collected. In contrast, only 2 of 17 spectra 
from the cytoplasm,  1 of 16 spectra from the Epon,  and  0  of 16 spectra from 
the nucleus contained a sulfur peak. 
aSS-Labeled JTB18 cloned cells treated with chondroitinase  ABC in the pres- 
ence or absence of 1 mg of chondroitin  sulfate C  carrier  released <1%  of the 
total cell-associated 35S-radioactivity in each experiment (n =  3) during a  15-min 
incubation  period  (data  not  shown).  In  contrast,  the  exogenous  chondroitin 
sulfate C was >99% (n =  2) digested to unsaturated disaccharides, indicating that 
the  enzyme  was not  inhibited  by the  presence  of the  NK cells.  That  the  3~S- 
labeled  proteoglycans  from  intact  NK  cells  were  not  susceptible to  digestion 
provides additional evidence that these proteoglycans were located intracellularly 
and,  in conjunction  with  the  x-ray energy-dispersive analysis,  within  secretory 
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FIGURE 6.  Representative  x-ray  spectra  from  JTB18  cells. (A)  granules;  (B)  nucleus; 
(C)  cytoplasm; (D)  Epon embedding resin. In all spectra, the arrow marks the position of the 
sulfur emission. In each spectrum, the peaks reading from left to right represent (A) sulfur, 
chlorine,  uranium, and two copper peaks; (B) phosphorus,  chlorine,  uranium, and two copper 
peaks;  (C) chlorine,  uranium,  and  two  copper peaks;  (D)  chlorine and  two  copper peaks. 
Chlorine is a contaminant in the resin, and copper is present in the support grid.  Uranium is 
from the uranyl acetate stain. However, the sulfur and phosphorus peaks are specific to the 
granular proteoglycan and the nuclear DNA, respectively.  All spectra  are unsmoothed, and 
are displayed with the same vertical scale, which has a maximum of 256 counts per channel. 
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FIGURE 7.  Time-dependent net percent exocytosis of sss-labeled proteoglycans from JTB18 
cells incubated at 0.5:1  ratios  with K562  (&) or KG1 (O) targets for defined intervals.  The 
spontaneous release  values for ssS-labeled proteoglycan during the 30-, 60-,  120-, and 240- 
min time intervals were 1, 2, 3, and 3%, respectively. 
Exocytosis  of 35S-labeled Proteoglycans  Triggered Specifically  by  Sensitive Tar- 
gets.  When the cloned 35S-labeIedJTB18 ceils were incubated from 30-240  min 
with  susceptible  targets  such  as  K562  cells,  35S-labeled  proteoglycans  were 
exocytosed, whereas incubation with resistant targets,  such as KG1  cells, did not 
result in incremental proteoglycan release (Fig. 7). The net percent of 35S-labeled 
proteoglycans released  increased rapidly during the first 60 min of culture,  with 
a  plateau  after 60 min of incubation,  as shown in the representative  experiment 
in  Fig.  7,  performed  at  a  0.5:1  effector/target  cell  ratio.  A  similar  effect  of 
incubation  time  was observed at effector/target  cell  ratios  from  0.5:1  to 5:1  in 
two other experiments,  and no further  release  was observed in one experiment 
with  an  8-h  incubation  period  (data  not  shown).  The  exocytosis of ~5S-labeled 
proteoglycans  from  these  human  NK  cells  was  dependent  upon  the  effec- 
tor/target  cell  ratio  (Fig.  8),  with  a  maximum  net  percent  of the  radiolabeled MAcDERMOTT  ET  AL.  1781 
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FIGURE 8.  Effect of different effector/target cell ratios on the net percent exocytosis of 3sS- 
labeled proteoglycans from the JTR18 cell incubated with K562 targets for 4 h. 
proteoglycan being exocytosed upon exposure of the NK cells to equal or greater 
numbers  of specific target  cells.  When  the  resistant  target  KG1  was used,  no 
more than 3% (n =  3) of the 35S-labeled proteoglycan was specifically released at 
any of the effector/target cell ratios examined (data not shown). 
The JTB18 clone is cytolytic for certain  targets,  such as K562,  Molt4,  REX, 
and CEM, but does not kill  KG1  or Laz156 (22).  The net percent cytotoxicity 
mediated by the JTB18  cloned  NK ceils against various targets  was compared 
with  the  net  percent  proteoglycan  release  induced  by  these  same  targets  in 
parallel  assays. The  induction  of exocytosis of proteoglycans from the  NK cell 
by specific targets was related to the degree of cytotoxicity of the  NK cell for 
the same targets (Table I). In this experiment, the K562 target induced a mean 
49% net release of ~SS-labeled  proteoglycan from the NK cell. 
Discussion 
These studies demonstrate the presence of a chondroitin sulfate A proteogly- 
can  in  the  granules  of a  cloned  human  NK  cell  and  induction  of its  specific 
exocytosis by target cells sensitive to lysis. For these studies, a clone (ITB 18) was 
used  with  a  phenotype  typical  of peripheral  blood  NK  cells.  These  cells are 
similar in ultrastructure to peripheral blood human LGL isolated by fluorescence- 
activated cell sorting (Figs.  1 and 2). The cloned cells also resembled published 
descriptions of LGL isolated by a  combination  of gradient  and rosetting  tech- 
niques (31-36),  with the exception  that  parallel  tubular arrays were not seen. 
Although some authors have considered these structures to be characteristic  of 
LGL (33, 34, 36), they have not been observed in all studies (31, 32, 35). When 
the human  cloned NK cell JTB18 was cultured for 24 h  in medium containing 
[35S]sulfate,  radioactivity was incorporated into macromolecules in a linear fash- 
ion (Fig.  3).  Because even after 24 h  of culture,  most of the newly synthesized 
35S-labeled macromolecules were not released, the NK cell-produced 35S-labeled 
macromolecules were destined to remain cell associated. 
The first indication that these ~S-labeled macromolecules were proteoglycans 
was their  possession  of a  buoyant  density  in  CsCI  typical  of proteoglycans  in 
secretory  granules  (17).  Upon  filtration  of the  density  gradient-purified  ~5S- 1782  PROTEOGLYCANS  IN  CELL-MEDIATED  CYTOTOXICITY 
TABLE  I 
Net Cytotoxicity and Net Proteoglycan Release with JTB18 Cloned NK 
Cells and Either Sensitive or Resistant Targets 
Net proteoglycan  Targets  Net cytotoxicity  release 
% 
Sensitive 
REX  82  36 
K562  77  49 
Molt4  73  39 
CEM  65  27 
Resistant 
KG1  15  2 
Laz156  8  0 
Cells were incubated for 4 h at an effector/target ratio of 0.5:1 for the 
net percent release of proteoglycan and 10:1 for the net percent cytotox- 
icity.  Numbers are  means for  three experiments performed  simultane- 
ously, in which both cytotoxicity and proteoglycan release were analyzed. 
The cytotoxicity experiments were performed in quadruplicate, and the 
proteoglycan release experiments were performed in duplicate. 
labeled proteoglycans on Sepharose CL-4 B (Fig.  4 A),  a polydispersed peak of 
radioactivity  with  a  Kay  of 0.42-0.47  was obtained,  indicating  -200,000  Mr. 
When these 35S-labeled NK cell proteoglycans were incubated with pronase or 
V8 protease and again chromatographed,  their filtration was unchanged (Fig. 4 
A). Because protease-resistant proteoglycans have been found in the granules of 
rat serosal mast cells (15), mouse bone marrow-derived mast cells (37), and rat 
basophilic leukemia cells (16),  it seemed possible that  these NK cell-associated 
proteoglycans belonged to a unique family of proteoglycans that reside intracel- 
lularly in granules,  rather than on the plasma membrane or in the extracellular 
matrix. Glycosaminoglycan analysis of the purified NK cell proteoglycan revealed 
the presence of chains with ~50,000 Mr (Fig.  4 B).  Because these glycosamino- 
glycans were equally sensitive to digestion with chondroitinase  ABC and chon- 
droitinase  AC,  it  was  concluded  that  chondroitin  sulfate  chains  containing 
glucuronic acid rather  than  iduronic acid were attached to the peptide core of 
this proteoglycan. HPLC analyses of the chondroitinase digests revealed only the 
disaccharide  ADi-4S  (Fig.  5),  indicating  that  these  glycosaminoglycans  were 
exclusively chondroitin sulfate A. Thus, the chondroitin sulfate glycosaminogly- 
cans on the proteoglycans from this human cloned NK cell were different from 
those on  the proteoglycans of the  mouse bone marrow-derived  mast cell (17) 
and the rat basophilic leukemia cell (16), in  that  they were larger (Mr) and  did 
not contain substantial amounts of disulfated disaccharides. 
Mouse cloned NK cells (38,  39),  human  peripheral  blood rnononuclear  cells 
(40),  and  human  T  cell  lines (40) possess cell-associated proteoglycans bearing 
chondroitin  sulfate  glycosaminoglycan  side  chains.  Transmission  electron  mi- 
croscopy and autoradiography localized 35S-labeled molecules to the cytoplasmic 
granules  of one  clone  of  35S-labeled  mouse  NK  cells,  suggesting  that  these 
proteoglycans are present in the secretory granules (39). In this study, sulfur was MAcDERMOTT  ET  AL.  1783 
detected in the granule of the JTB 18 cells by x-ray energy-dispersive spectroscopy 
(Fig. 6).  This sulfur is most likely present as sulfate bound to the proteoglycan 
molecule, because ionic sulfate is normally lost during the processing procedure, 
and because it is highly unlikely that sulfur-containing amino acids are present 
in sufficient concentration to provide detectable signals.  The failure to detect 
sulfur  in  17%  of the  granules  is  most  likely due  to  technical difficulties in 
identifying and measuring poorly visualized granules, although a lack of proteo- 
glycan in a small population of the granules cannot be ruled out. However, the 
presence of these sulfur-containing molecules in most of the granules (Fig.  6), 
coupled with the absence of chondroitinase ABC-susceptible ~S-labeled proteo- 
glycans on  the surface of the NK cell, indicates that  most of the chondroitin 
sulfate A proteoglycans of the  JTB 18 cell are located within the secretory granules 
of the cell. 
Specific exocytosis of chondroitin sulfate A  proteoglycans from the granules 
of the 35S-labeled  cloned JTB18  cell occurred during exposure of the cells to 
JTB18-susceptible target cells such as K562, REX, Molt4, and CEM, but not to 
JTB18-resistant  targets such as KG1  or  Laz156  (Table  I).  The stimulation of 
proteoglycan release by K562 targets was time dependent, reaching a plateau at 
~60 rain (Fig. 7), and was optimal at an effector/target cell ratio of 0.5:1, with 
progressively less  release  being obtained at  increasing ratios  (Fig.  8).  A  cell- 
associated proteoglycan of 200,000  Mr containing only chondroitin sulfate A 
glycosaminoglycans  was also produced by a human NK clone, CNK8 (T3 +, T 11 +, 
NKH1 +,  NKH2+).  Exocytosis of the 35S-labeled  proteoglycan from the CNK8 
cell was also stimulus specific, being 53% upon incubation with the K562 sensitive 
target, and 3%  for the CEM-resistant target. The correlation of proteoglycan 
release with target cell susceptibility, coupled with the inhibition of proteoglycan 
release  by  monocional  antibodies  that  block JTBI8  and  CNK8  cytotoxicity 
indicates  that  specific  NK  effector cell  receptors and  target  cell  recognition 
structures are involved in triggering proteoglycan exocytosis (42). The ability to 
define one of the granule constituents, proteoglycan, exocytosed from the NK 
cell via receptor-mediated activation should enable the identification of other 
granule-associated molecules and their possible association with this proteoglycan 
molecule. 
Because of stimulation of their specific release by N K-susceptible targets, there 
are several possible roles for chondroitin sulfate A proteoglycans in cell-mediated 
cytotoxicity, Due to its acidic nature, chondroitin sulfate A proteoglycan may act 
as  a  packaging  and/or  carrier  molecule that  forms  complexes  with  cationic 
cytolysins or perforins (9-13) and/or other proteins (5, 6). A serine esterase has 
been recently identified in mouse cytotoxic T cell clones (41), and the chondroitin 
sulfate A proteoglycan could function as a carrier for analogous human proteases. 
Such complexes could reduce granule osmotic pressure before secretion, thereby 
condensing the size of the granule and making storage more efficient. 
Alternatively, the chondroitin sulfate A proteoglycans may protect the NK cell 
from being lysed by the cytotoxic molecules in the granules. Before seccetion, 
the proteoglycan may orient the lytic proteins and prevent iysis of the granule 
membrane. After secretion, the complex of proteoglycan and cytotoxic molecules 
may persist and permit the transfer of the cytotoxic molecules to the membrane 1784  PROTEOGLYCANS  IN  CELL-MEDIATED  CYTOTOXICITY 
of the  target  cell.  Thus,  the  proteoglycan  molecule  may allow  the  cytotoxic 
effector cell  to  deliver  a  series  of lethal  hits  to  target  cells without  incurring 
damage. 
On the target cell membrane, chondroitin sulfate A proteoglycans may either 
participate  in the assembly of the lytic subunits or act as insertion  molecules in 
the final ring-forming structure.  Their large size, with multiple glycosaminogly- 
can side chains, could bind and orient multiple lytic subunits in a ring formation. 
Alternatively, a terminal hydrophobic region of the peptide core could promote 
lytic complex insertion into the target cell membrane. 
Summary 
A  clone of natural  killer (NK) cells (JTB18) was found to be ultrastructurally 
similar to peripheral blood large granular lymphocytes (LGL). These cells incor- 
porated [35S]sulfate into cell-associated proteoglycan molecules, which were then 
isolated  by CsC1 density gradient  centrifugation.  As  assessed  by gel  filtration 
chromatography,  the  native  ~sS-labeled proteoglycan and  its /3-eliminated  35S- 
labeled glycosaminoglycans were of Mr ~200,000 and 50,000, respectively. The 
a5S-labeled  proteoglycans  were  resistant  to  proteolysis,  since  their  Mr  were 
apparently not altered by incubation with either pronase or S. aureus V8 protease. 
The purified NK cell 35S-labeled proteoglycans were degraded by ~90% to 35S- 
labeled disaccharides with either chondroitinase ABC or AC. High performance 
liquid chromatographic analysis of the digests revealed these disaccharides to be 
composed entirely of chondroitin  sulfate A  (glucuronic acid ---+ N-acetylgalacto- 
samine-4SO4). Whole 35S-labeled cells incubated with chondroitinase ABC failed 
to  release  ~sS-labeled  disaccharides  into  the  supernatant,  and  x-ray  energy- 
dispersive analysis revealed that sulfur-containing molecules were present in the 
intracellular  granules,  thereby  localizing  the  NK  cell-associated  proteoglycan 
primarily in the granules of the cell, rather than on the plasma membrane. 
The ~5S-labeled  cloned NK cells incubated for 30 min to 4 h with K562 tumor 
cell targets at a 0.5:1 ratio exocytosed a mean of 49% of the granular asS-labeled 
proteoglycans during  the first 60 min of the culture.  Proteoglycan release was 
maximal  with an effector/target cell ratio of 0.5:1  for JTB18:K562.  Significant 
proteoglycan release from JTB18 NK cells was also obtained with other sensitive 
target cells such as REX, Molt4, and CEM, but not with cells such as KG1  and 
Laz156, which have been shown previously (22) to be resistant to killing by this 
NK  cell.  Thus,  protease-resistant  intracellular  proteoglycans  with  chondroitin 
sulfate A side chains are specifically exocytosed from the granules of human NK 
effector cells upon contact with sensitive targets, suggesting that these proteogly- 
cans may be involved in the mechanism of cytotoxicity. 
We thank M. Bertovich for technical contributions. 
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